Cargando…
Mucosal Administration of Recombinant Baculovirus Displaying Toxoplasma gondii ROP4 Confers Protection Against T. gondii Challenge Infection in Mice
Pathogens require physical contact with the mucosal surface of the host organism to initiate infection and as such, vaccines eliciting both mucosal and systemic immune responses would be promising. Studies involving the use of recombinant baculoviruses (rBVs) as mucosal vaccines are severely lacking...
Autores principales: | Yoon, Keon-Woong, Chu, Ki-Back, Kang, Hae-Ji, Kim, Min-Ju, Eom, Gi-Deok, Lee, Su-Hwa, Moon, Eun-Kyung, Quan, Fu-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512701/ https://www.ncbi.nlm.nih.gov/pubmed/34660343 http://dx.doi.org/10.3389/fcimb.2021.735191 |
Ejemplares similares
-
Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Toxoplasma gondii Challenge Infection
por: Yoon, Keon-Woong, et al.
Publicado: (2022) -
Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing Toxoplasma gondii Rhoptry Protein 18
por: Yoon, Keon-Woong, et al.
Publicado: (2022) -
Detection of Toxoplasma gondii Infections using Virus-Like Particles Displaying T. gondii ROP4 Antigen
por: Kim, Min-Ju, et al.
Publicado: (2021) -
ROP18-Mediated Transcriptional Reprogramming of HEK293T Cell Reveals New Roles of ROP18 in the Interplay Between Toxoplasma gondii and the Host Cell
por: Li, Jie-Xi, et al.
Publicado: (2020) -
Recombinant AMA1 Virus-like Particle Antigen for Serodiagnosis of Toxoplasma gondii Infection
por: Kim, Min-Ju, et al.
Publicado: (2022)